A secret that hides Vera Therapeutics Inc’s strength (NASDAQ:VERA)

In yesterday’s Wall Street session, Vera Therapeutics Inc (NASDAQ:VERA) shares traded at $42.19, up 0.21% from the previous session.

VERA stock price is now -7.21% away from the 50-day moving average and 3.62% away from the 200-day moving average. The market capitalization of the company currently stands at $2.67B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target of $70, Wells Fargo recently initiated with Overweight rating for Vera Therapeutics Inc (NASDAQ: VERA). , while ‘Oppenheimer’ rates the stock as ‘Outperform’

In other news, MARSHALL FORDYCE, Director bought 17,500 shares of the company’s stock on Jan 08 ’25. The stock was bought for $736,750 at an average price of $42.10. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 18 ’24, PRESIDENT AND CEO Fordyce Marshall sold 17,500 shares of the business’s stock. A total of $753,680 was realized by selling the stock at an average price of $43.07. This leaves the insider owning 85,942 shares of the company worth $3.63 million. A total of 22.63% of the company’s stock is owned by insiders.

During the past 12 months, Vera Therapeutics Inc has had a low of $14.20 and a high of $51.61. As of last week, the company has a debt-to-equity ratio of 0.19, a current ratio of 13.60, and a quick ratio of 13.60. The fifty day moving average price for VERA is $45.446 and a two-hundred day moving average price translates $40.709 for the stock.

The latest earnings results from Vera Therapeutics Inc (NASDAQ: VERA) was released for 2024-09-30. The company reported revenue of $49.8 million for the quarter, compared to $21.76 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 128.91 percent.

Related Posts